FDA-Inspected Site

Mylan Laboratories Limited

9 FDA inspections are on record for Mylan Laboratories Limited in Bangalore, India.

Clean· No action indicated

Bangalore, India · Last updated July 9, 2026

Overview

  • 9 FDA inspections are on record.
  • 8 inspections produced a Form 483.
  • The most recent recorded inspection date is 2023-02-24.

At a glance

Inspections

9

Form 483s

8

EIRs

1

Last outcome

Clean

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
16 Feb 2023 – 24 Feb 2023Human DrugsClean
9 Jan 2023 – 16 Jan 2023Human Drugs483On file
20 Feb 2020 – 28 Feb 2020Human Drugs483View 483 →
6 May 2019 – 13 May 2019Human Drugs483View 483 →
22 Feb 2018 – 2 Mar 2018Human Drugs483View 483 →
10 Apr 2017 – 18 Apr 2017Human Drugs483View 483 →
4 Apr 2016 – 13 Apr 2016Human Drugs483On file
23 Sep 2014 – 3 Oct 2014Human DrugsWLOn file
17 Jun 2013 – 27 Jun 2013Human Drugs483On file

Observations on record

Form 483 observations cited at this site, most recent first.

28 Feb 2020
21 CFR 211.110(a)

Control procedures to monitor and validate performance

Cited by Linda F Murphy, Steven M Weinman

28 Feb 2020
21 CFR 211.160(b)

Scientifically sound laboratory controls

Cited by Linda F Murphy, Steven M Weinman

28 Feb 2020
21 CFR 211.192

Written record of investigation incomplete

Cited by Linda F Murphy, Steven M Weinman

28 Feb 2020
21 CFR 211.22(d)

Procedures not in writing, fully followed

Cited by Linda F Murphy, Steven M Weinman

28 Feb 2020
21 CFR 211.42(c)(10)(iv)

Environmental Monitoring System

Cited by Linda F Murphy, Steven M Weinman

Investigators

FDA investigators tied to this site in the record.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
21 CFR 211.22(d)Cited across public-safe Form 483 observations4x
21 CFR 211.110(a)Cited across public-safe Form 483 observations3x
21 CFR 211.160(b)Cited across public-safe Form 483 observations3x
21 CFR 211.192Cited across public-safe Form 483 observations3x
21 CFR 211.100(b)Cited across public-safe Form 483 observations2x
21 CFR 211.198(a)Cited across public-safe Form 483 observations2x
21 CFR 211.25(c)Cited across public-safe Form 483 observations2x
21 CFR 211.67(a)Cited across public-safe Form 483 observations2x
21 CFR 211.113(b)Cited across public-safe Form 483 observations1x
21 CFR 211.42(a)Cited across public-safe Form 483 observations1x
21 CFR 211.42(c)(10)(iv)Cited across public-safe Form 483 observations1x
21 CFR 211.42(c)(9)Cited across public-safe Form 483 observations1x
21 CFR 211.46(b)Cited across public-safe Form 483 observations1x
21 CFR 211.46(c)Cited across public-safe Form 483 observations1x
21 CFR 211.63Cited across public-safe Form 483 observations1x
21 CFR 211.65(a)Cited across public-safe Form 483 observations1x
21 CFR 211.67(b)Cited across public-safe Form 483 observations1x
21 CFR 211.68(b)Cited across public-safe Form 483 observations1x

Full site report

Get the verbatim findings behind Mylan Laboratories Limited's 8 Form 483s

Source PDFs, verbatim observations, and recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat